Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits

Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,290.00, down by ₹6.00, or 0.26%, on the BSE.

Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,290.00, down by ₹6.00, or 0.26%, on the BSE.

Shares of Tenneco Clean Air India Ltd ended at ₹550.00, down by ₹4.30, or 0.78%, on the BSE.

Catastrophe bonds pay high interest when disaster stays away but can cost investors their money when it strikes. Now, India is exploring the idea too.

The casino operator slipped into the red after setting aside ₹306.73 crore for GST, interest and penalties, while revenue fell 8.5% year-on-year.

Shares of Dr Agarwals Health Care Ltd ended at ₹542.75, down by ₹19.30, or 3.43%%, on the BSE.

Sentynl Therapeutics has secured an option for US commercial rights to alvelestat, a potential first oral treatment for a rare genetic lung disease affecting up to 80,000 Americans.

Revenue declined 10% and operating margin narrowed sharply to 21.6%, though both sales and profit improved from the March quarter.

Tuesday’s earnings brought a mixed bag, with MRF and Zydus Lifesciences facing margin pressure, while RVNL, NBCC and Manappuram Finance delivered stronger operating performances. Meanwhile, management commentary from TVS Supply Chain, RateGain and Embassy Developments pointed to a positive growth…

HCL Tech’s C Vijayakumar and L&T’s SN Subrahmanyan crossed ₹100 crore in annual pay, while SBI’s chief was the lowest-paid among Nifty 50 CEOs.

Foreign investors bought a net ₹259 crore of equities on Tuesday, while domestic institutions turned buyers after selling ₹1,290 crore in the previous session.